POSC4 Modeling Health-Related Outcomes With Avelumab as a First-Line Maintenance Treatment Following Chemotherapy vs. Best Supportive Care (BSC) for Patients With Locally Advanced or Metastatic Urothelial Cancer in the UK
Jan 1, 2022, 00:00 AM
10.1016/j.jval.2021.11.150
https://www.valueinhealthjournal.com/article/S1098-3015(21)01945-8/fulltext
Section Title :
Section Order :
10917
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(21)01945-8&doi=10.1016/j.jval.2021.11.150